Chris Bauer
Overview
Explore the profile of Chris Bauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Selevsek N, Caiment F, Nudischer R, Gmuender H, Agarkova I, Atkinson F, et al.
Commun Biol
. 2020 Oct;
3(1):573.
PMID: 33060801
Uncovering cellular responses from heterogeneous genomic data is crucial for molecular medicine in particular for drug safety. This can be realized by integrating the molecular activities in networks of interacting...
22.
Fuentes M, Klostermann A, Kleineidam L, Bauer C, Schuchhardt J, Maier W, et al.
J Alzheimers Dis
. 2020 Jun;
76(3):1005-1015.
PMID: 32597807
Background: Cognitive functions and activities of daily living (ADL) become increasingly impaired with progressing Alzheimer's disease. However, the temporal dynamics of this decline are inconsistent. Objective: To gain insight into...
23.
Wittenbrink N, Herrmann S, Blazquez-Navarro A, Bauer C, Lindberg E, Wolk K, et al.
BMC Immunol
. 2019 Apr;
20(1):11.
PMID: 31029086
Background: Acute cellular rejection (ACR) is associated with complications after kidney transplantation, such as graft dysfunction and graft loss. Early risk assessment is therefore critical for the improvement of transplantation...
24.
Santos J, Bauer C, Schuchhardt J, Wedekind D, Waniek K, Lachmann I, et al.
J Neural Transm (Vienna)
. 2019 Feb;
126(3):339-348.
PMID: 30767082
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the presence of extracellular amyloid plaques (senile plaques) and intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein. This process leads...
25.
Shahpasand-Kroner H, Klafki H, Bauer C, Schuchhardt J, Huttenrauch M, Stazi M, et al.
Alzheimers Res Ther
. 2018 Dec;
10(1):121.
PMID: 30526652
Background: The quantification of amyloid-beta (Aβ) peptides in blood plasma as potential biomarkers of Alzheimer's disease (AD) is hampered by very low Aβ concentrations and the presence of matrix components...
26.
Blazquez-Navarro A, Dang-Heine C, Wittenbrink N, Bauer C, Wolk K, Sabat R, et al.
EBioMedicine
. 2018 Aug;
34:113-121.
PMID: 30072213
Background: BK virus (BKV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations are common after kidney transplantation and associated with increased morbidity and mortality. Although CMV might be a risk factor...
27.
Virant-Klun I, Bauer C, Stahlberg A, Kubista M, Skutella T
Reprod Biomed Online
. 2018 Mar;
36(5):508-523.
PMID: 29503212
The conventional method of human oocyte maturation in vitro in the presence of gonadotrophins continues to be a relatively low-success procedure in the assisted conception programme owing to suboptimal maturation...
28.
Frolich L, Peters O, Lewczuk P, Gruber O, Teipel S, Gertz H, et al.
Alzheimers Res Ther
. 2017 Oct;
9(1):84.
PMID: 29017593
Background: The progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia can be predicted by cognitive, neuroimaging, and cerebrospinal fluid (CSF) markers. Since most biomarkers reveal complementary information,...
29.
Klafki H, Hafermann H, Bauer C, Haussmann U, Kraus I, Schuchhardt J, et al.
J Alzheimers Dis
. 2016 Aug;
54(2):691-705.
PMID: 27567847
A comprehensive assay validation campaign of a commercially available chemiluminescence multiplex immunoassay for the simultaneous measurement of the amyloid-β peptides Aβ38, Aβ40, and Aβ42 in human cerebrospinal fluid (CSF) is...
30.
Bauer C, Stec K, Glintschert A, Gruden K, Schichor C, Or-Guil M, et al.
Cancer Inform
. 2015 May;
14:55-63.
PMID: 26005322
Personalized medicine is promising a revolution for medicine and human biology in the 21st century. The scientific foundation for this revolution is accomplished by analyzing biological high-throughput data sets from...